Hepatoblastoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Podcasts
• Clinical Trials

the Efficacy and Safety of Sugammadex in Children 0-2 Years Old
Conditions:   Anesthesia;   Pediatric Cancer;   Pediatric Tumor;   Pediatric Hepatoblastoma;   Beta-Thalassemia;   Hepatic Metastases Intervention:   Drug: Sugammadex Sponsor:   Federal Research Institute of Pediatric Hematology, Oncology and Immunology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2018 Category: Research Source Type: clinical trials